HOW EPAT SHOCKWAVE THERAPY WORKS

HOW ESWT WORKS

Extracorporeal Pulse Activation Technology (EPAT) accelerates the healing process in the body by stimulating the metabolism and enhancing blood circulation to regenerate damaged tissue. Strong energy pulses are applied to the affected area. These pulses occur for short periods of time, creating micro-cavitation bubbles that expand and burst. The force created by these bubbles penetrates tissue and stimulates cells in the body that are responsible for bone and connective tissue healing. In many instances, pressure wave technology is most effective in cases where the human body has not been able to heal itself on its own.

TECHNOLOGY

Extracorporeal Pulse Activation Technology (EPAT) is a modern and highly effective treatment method: high-energy sound waves are introduced into the painful areas of the body. With this innovative therapy approach, pathological alterations of tendons, ligaments, capsules, muscles and bones can be eliminated systematically.

BENEFITS

There are numerous benefits from EPAT  

• Non-Surgical 
• No Side Effects 
• Accelerated Healing 
• Ease of Use
• Affordable
• 91% Success Rate*
• Non-invasive
• No Anesthesia Required
• No Risk of Infection
• No Scarring
• No Downtime
• Over 80% Patient Satisfaction
• Faster, Easier Healing

The beneficial effects of pressure wave therapy are often experienced after only 1 or 2 treatments. The therapy eliminates pain and restores full mobility, thus improving your quality of life.

PROPOSED MECHANISM OF EXTRACORPOREAL SHOCKWAVE THERAPY (ESWT)

Source: Dr. Wang
Extracorporeal Shockwave Therapy (ESWT) clinical results, technology basics, GERDESMEYER 2007, page 52

 

Extracorporeal Pulse Activation Technique (EPAT) is approved in the US by the Food and Drug Administration (FDA) for treatment of plantar fasciitis and tennis elbow. There is an FDA study to treat recalcitrant diabetic wounds. The FDA approved STORZ D-ACTOR 100 device to administer ESWT.

The UK advisory body, the National Institute for Health and Care Excellence (NICE), have issued guidance on ESWT to UK clinicians for a number of clinical indications including calcific tendinitis of the shoulder, refractory plantar fascitiis, refractory Achilles tendinopathy, refractory tennis elbow, and refractory greater trochanteric pain syndrome.